Esperion Therapeutics Inc logo

Esperion Therapeutics Inc

1
NEW
NAS:ESPR (USA)   Ordinary Shares
$ 2.13 +0.05 (+2.4%) 12:09 AM EST
At Loss
Market Cap:
$ 417.96M
Enterprise V:
$ 489.94M
Volume:
2.78M
Avg Vol (2M):
3.12M
Trade In:
Volume:
2.78M
At Loss
Avg Vol (2M):
3.12M

Business Description

Esperion Therapeutics Inc logo
Esperion Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US29664W1053

Share Class Description:

ESPR: Ordinary Shares
Description
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Name Current Vs Industry Vs History
Cash-To-Debt 0.7
Equity-to-Asset -0.98
Debt-to-Equity -0.78
Debt-to-EBITDA -6.62
Interest Coverage 0.09
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.82
Distress
Grey
Safe
Beneish M-Score 0.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.39
9-Day RSI 60.11
14-Day RSI 58.78
6-1 Month Momentum % -16.24
12-1 Month Momentum % 99.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.97
Quick Ratio 1.49
Cash Ratio 1.08
Days Inventory 462.89
Days Sales Outstanding 64.88
Days Payable 229.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -65.8
Shareholder Yield % -23.48

Financials

ESPR's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ESPR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Esperion Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 277.788
EPS (TTM) ($) -0.86
Beta 0.87
Volatility % 150.18
14-Day RSI 58.78
14-Day ATR ($) 0.123815
20-Day SMA ($) 2.063
12-1 Month Momentum % 99.69
52-Week Range ($) 0.8101 - 3.4
Shares Outstanding (Mil) 196.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Esperion Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Esperion Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Esperion Therapeutics Inc Frequently Asked Questions

What is Esperion Therapeutics Inc(ESPR)'s stock price today?
The current price of ESPR is $2.13. The 52 week high of ESPR is $3.40 and 52 week low is $0.81.
When is next earnings date of Esperion Therapeutics Inc(ESPR)?
The next earnings date of Esperion Therapeutics Inc(ESPR) is .
Does Esperion Therapeutics Inc(ESPR) pay dividends? If so, how much?
Esperion Therapeutics Inc(ESPR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1